These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 29177411)
1. Ultrasmall Superparamagnetic Iron Oxide Imaging Identifies Tissue and Nerve Inflammation in Pain Conditions. Shen S; Ding W; Ahmed S; Hu R; Opalacz A; Roth S; You Z; Wotjkiewicz GR; Lim G; Chen L; Mao J; Chen JW; Zhang Y Pain Med; 2018 Apr; 19(4):686-692. PubMed ID: 29177411 [TBL] [Abstract][Full Text] [Related]
2. Ultrasmall superparamagnetic iron oxide nanoparticle uptake as noninvasive marker of aortic wall inflammation on MRI: proof of concept study. Hedgire S; Krebill C; Wojtkiewicz GR; Oliveira I; Ghoshhajra BB; Hoffmann U; Harisinghani MG Br J Radiol; 2018 Dec; 91(1092):20180461. PubMed ID: 30160173 [TBL] [Abstract][Full Text] [Related]
3. Comparison of Three Ultrasmall, Superparamagnetic Iron Oxide Nanoparticles for MRI at 3.0 T. Colbert CM; Ming Z; Pogosyan A; Finn JP; Nguyen KL J Magn Reson Imaging; 2023 Jun; 57(6):1819-1829. PubMed ID: 36250695 [TBL] [Abstract][Full Text] [Related]
4. Ferumoxytol administration does not alter infarct volume or the inflammatory response to stroke in mice. Doyle KP; Quach LN; Arceuil HE; Buckwalter MS Neurosci Lett; 2015 Jan; 584():236-40. PubMed ID: 25449870 [TBL] [Abstract][Full Text] [Related]
6. Imaging Tumor Necrosis with Ferumoxytol. Aghighi M; Golovko D; Ansari C; Marina NM; Pisani L; Kurlander L; Klenk C; Bhaumik S; Wendland M; Daldrup-Link HE PLoS One; 2015; 10(11):e0142665. PubMed ID: 26569397 [TBL] [Abstract][Full Text] [Related]
7. Ferumoxytol-enhanced magnetic resonance imaging methodology and normal values at 1.5 and 3T. Stirrat CG; Alam SR; MacGillivray TJ; Gray CD; Forsythe R; Dweck MR; Payne JR; Prasad SK; Petrie MC; Gardner RS; Mirsadraee S; Henriksen PA; Newby DE; Semple SI J Cardiovasc Magn Reson; 2016 Jul; 18(1):46. PubMed ID: 27465647 [TBL] [Abstract][Full Text] [Related]
8. A comparison of ferumoxytol with gadolinium as contrast agents for the diagnostic magnetic resonance imaging of osteomyelitis. Langsjoen J; Neuwelt A; Eberhardt S; Mlady G; Shukla U; Murali S; Pizanis C; Sillerud LO Magn Reson Imaging; 2020 Sep; 71():45-54. PubMed ID: 32439428 [TBL] [Abstract][Full Text] [Related]
9. Dynamic changes of inflammation and apoptosis in cerebral ischemia‑reperfusion injury in mice investigated by ferumoxytol‑enhanced magnetic resonance imaging. Zhuang L; Kong Y; Yang S; Lu F; Gong Z; Zhan S; Liu M Mol Med Rep; 2021 Apr; 23(4):. PubMed ID: 33604682 [TBL] [Abstract][Full Text] [Related]
10. Feasibility of islet magnetic resonance imaging using ferumoxytol in intraportal islet transplantation. Jin SM; Oh SH; Oh BJ; Shim W; Choi JM; Yoo D; Hwang YH; Lee JH; Lee DY; Kim JH Biomaterials; 2015 Jun; 52():272-80. PubMed ID: 25818433 [TBL] [Abstract][Full Text] [Related]
11. Macrophage Imaging of Cerebral Aneurysms with Ferumoxytol: an Exploratory Study in an Animal Model and in Patients. Aoki T; Saito M; Koseki H; Tsuji K; Tsuji A; Murata K; Kasuya H; Morita A; Narumiya S; Nozaki K; J Stroke Cerebrovasc Dis; 2017 Oct; 26(10):2055-2064. PubMed ID: 28774792 [TBL] [Abstract][Full Text] [Related]
12. Differential uptake of ferumoxtran-10 and ferumoxytol, ultrasmall superparamagnetic iron oxide contrast agents in rabbit: critical determinants of atherosclerotic plaque labeling. Yancy AD; Olzinski AR; Hu TC; Lenhard SC; Aravindhan K; Gruver SM; Jacobs PM; Willette RN; Jucker BM J Magn Reson Imaging; 2005 Apr; 21(4):432-42. PubMed ID: 15779033 [TBL] [Abstract][Full Text] [Related]
13. MRI assessment of hepatic iron clearance rates after USPIO administration in healthy adults. Storey P; Lim RP; Chandarana H; Rosenkrantz AB; Kim D; Stoffel DR; Lee VS Invest Radiol; 2012 Dec; 47(12):717-24. PubMed ID: 23070094 [TBL] [Abstract][Full Text] [Related]
14. Ferumoxytol nanoparticle uptake in brain during acute neuroinflammation is cell-specific. McConnell HL; Schwartz DL; Richardson BE; Woltjer RL; Muldoon LL; Neuwelt EA Nanomedicine; 2016 Aug; 12(6):1535-42. PubMed ID: 27071335 [TBL] [Abstract][Full Text] [Related]
15. Comparative analysis of ferumoxytol and gadoteridol enhancement using T1- and T2-weighted MRI in neuroimaging. Hamilton BE; Nesbit GM; Dosa E; Gahramanov S; Rooney B; Nesbit EG; Raines J; Neuwelt EA AJR Am J Roentgenol; 2011 Oct; 197(4):981-8. PubMed ID: 21940589 [TBL] [Abstract][Full Text] [Related]
16. Magnetic resonance imaging of experimental atherosclerotic plaque: comparison of two ultrasmall superparamagnetic particles of iron oxide. Herborn CU; Vogt FM; Lauenstein TC; Dirsch O; Corot C; Robert P; Ruehm SG J Magn Reson Imaging; 2006 Aug; 24(2):388-93. PubMed ID: 16791857 [TBL] [Abstract][Full Text] [Related]
17. USPIO-Enhanced MRI Neuroimaging: A Review. Gkagkanasiou M; Ploussi A; Gazouli M; Efstathopoulos EP J Neuroimaging; 2016; 26(2):161-8. PubMed ID: 26932522 [TBL] [Abstract][Full Text] [Related]
18. Validation of MRI quantitative susceptibility mapping of superparamagnetic iron oxide nanoparticles for hyperthermia applications in live subjects. Deh K; Zaman M; Vedvyas Y; Liu Z; Gillen KM; O' Malley P; Bedretdinova D; Nguyen T; Lee R; Spincemaille P; Kim J; Wang Y; Jin MM Sci Rep; 2020 Jan; 10(1):1171. PubMed ID: 31980695 [TBL] [Abstract][Full Text] [Related]
19. Ultrasmall superparamagnetic iron-oxide-enhanced MR imaging of normal bone marrow in rodents: original research original research. Simon GH; Raatschen HJ; Wendland MF; von Vopelius-Feldt J; Fu Y; Chen MH; Daldrup-Link HE Acad Radiol; 2005 Sep; 12(9):1190-7. PubMed ID: 16099684 [TBL] [Abstract][Full Text] [Related]
20. Imaging behavior of the normal adrenal on ferumoxytol-enhanced MRI: preliminary findings. Gunn AJ; Seethamraju RT; Hedgire S; Elmi A; Daniels GH; Harisinghani MG AJR Am J Roentgenol; 2013 Jul; 201(1):117-21. PubMed ID: 23789664 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]